Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Mark Oki

Mark Oki is recorded as CFO at Achieve Life Sciences, Inc. (ACHV) and CFO at Aytu Biopharma, Inc (AYTU). The proxy statement of Achieve Life Sciences, Inc. reports total compensation of $1,015,388 for Mark Oki in fiscal 2024, including a base salary of $30,864. Mark Oki has spoken on 14 earnings calls across 2 companies, most recently for Achieve Life Sciences, Inc. on March 24, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Aytu Biopharma, Inc

Other people whose current roles at this company are on record from its filings.

Leadership on record at Achieve Life Sciences, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Achieve Life Sciences, Inc. (ACHV) $30,864 $1,015,388

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.